The Impact of Coronavirus Disease 2019 (COVID-19) Pandemic on Urologic Cancer Care: Did We Throw the Baby out with the Bathwater?

Overview

Journal Transl Androl Urol

Date 2023 Feb 10

PMID 36760874

Authors

Hubert Kamecki

Pawel Rajwa

Artur Przewor

Roman Sosnowski

Affiliations

Soon will be listed here.

References

Deukeren D, Heesterman B, Roelofs L, Kiemeney L, Witjes J, Smilde T . Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands. Cancer Treat Res Commun. 2022; 31:100553. PMC: 8975755. DOI: 10.1016/j.ctarc.2022.100553. View

Gouveia A, Moraes F, Lima R, Viani G . Impact of COVID-19 on the curative treatment of prostate cancer: a national cross-sectional study. Rep Pract Oncol Radiother. 2022; 27(4):659-665. PMC: 9521698. DOI: 10.5603/RPOR.a2022.0070. View

Cortis D, Vella King F . Back to basics: measuring the impact of interventions to limit the spread of COVID-19 in Europe. Arch Public Health. 2022; 80(1):76. PMC: 8904711. DOI: 10.1186/s13690-022-00830-5. View

Lee K, Bryant A, Alba P, Anglin T, Robison B, Rose B . Impact of COVID-19 on the incidence of localized and metastatic prostate cancer among White and Black Veterans. Cancer Med. 2022; 12(3):3727-3730. PMC: 9538539. DOI: 10.1002/cam4.5151. View

Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R . The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020; 21(8):1023-1034. PMC: 7417808. DOI: 10.1016/S1470-2045(20)30388-0. View

Grant M, Helsper C, Stellato R, van Erp N, van Asselt K, Slottje P . The Impact of the COVID Pandemic on the Incidence of Presentations with Cancer-Related Symptoms in Primary Care. Cancers (Basel). 2022; 14(21). PMC: 9656532. DOI: 10.3390/cancers14215353. View

Nyk L, Kamecki H, Zagozdzon B, Tokarczyk A, Baranek P, Mielczarek L . The Impact of the Ongoing COVID-19 Epidemic on the Increasing Risk of Adverse Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy. Curr Oncol. 2022; 29(4):2768-2775. PMC: 9027555. DOI: 10.3390/curroncol29040225. View

Ginsburg K, Curtis G, Timar R, George A, Cher M . Delayed Radical Prostatectomy is Not Associated with Adverse Oncologic Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic. J Urol. 2020; 204(4):720-725. DOI: 10.1097/JU.0000000000001089. View

Pujolar G, Oliver-Angles A, Vargas I, Vazquez M . Changes in Access to Health Services during the COVID-19 Pandemic: A Scoping Review. Int J Environ Res Public Health. 2022; 19(3). PMC: 8834942. DOI: 10.3390/ijerph19031749. View

10.

Diamand R, Ploussard G, Roumiguie M, Oderda M, Benamran D, Fiard G . Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic. World J Urol. 2020; 39(6):1789-1796. PMC: 7416303. DOI: 10.1007/s00345-020-03402-w. View

11.

Nossiter J, Morris M, Parry M, Sujenthiran A, Cathcart P, van der Meulen J . Impact of the COVID-19 pandemic on the diagnosis and treatment of men with prostate cancer. BJU Int. 2022; 130(2):262-270. DOI: 10.1111/bju.15699. View

12.

Haddad F, Kourie H, Gebara N, Matta C, Eid R, El Karak F . Cancer Patients in the Era of Coronavirus: What to Fear Most?. J Patient Saf. 2021; 17(1):e35-e38. DOI: 10.1097/PTS.0000000000000797. View

13.

Anderson S, Rigney K, Hayes L, Ryan P, Chaitanya V, Jacob P . A retrospective cohort study of bladder cancer following the COVID-19 pandemic: Are patients presenting with more aggressive disease?. Ann Med Surg (Lond). 2022; 81:104430. PMC: 9387060. DOI: 10.1016/j.amsu.2022.104430. View

14.

Amador M, Matias-Guiu X, Sancho-Pardo G, Contreras Martinez J, de la Torre-Montero J, Penuelas Saiz A . Impact of the COVID-19 pandemic on the care of cancer patients in Spain. ESMO Open. 2021; 6(3):100157. PMC: 8128716. DOI: 10.1016/j.esmoop.2021.100157. View

15.

Pepe P, Pepe L, Pennisi M, Fraggetta F . Prostate Cancer Diagnosis and Management During One Year of the COVID-19 Pandemic. Anticancer Res. 2021; 41(6):3127-3130. DOI: 10.21873/anticanres.15097. View

16.

Tulchiner G, Staudacher N, Fritz J, Radmayr C, Culig Z, Horninger W . The "COVID-19 Pandemic Gap" and Its Influence on Oncologic Outcomes of Bladder Cancer. Cancers (Basel). 2021; 13(8). PMC: 8067623. DOI: 10.3390/cancers13081754. View

17.

Garcia Barreras S, Minguez Ojeda C, Lopez Plaza J, Arribas Terradillas S, Fernandez Conejo G, Sanz Mayayo E . How has the COVID-19 pandemic influenced prostate cancer?-a tertiary single-centre analysis of oncological results, diagnosis and treatment times. Transl Androl Urol. 2023; 11(12):1637-1644. PMC: 9827396. DOI: 10.21037/tau-22-360. View

18.

Adam D . The pandemic's true death toll: millions more than official counts. Nature. 2022; 601(7893):312-315. DOI: 10.1038/d41586-022-00104-8. View

19.

Alfano V, Ercolano S . The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis. Appl Health Econ Health Policy. 2020; 18(4):509-517. PMC: 7268966. DOI: 10.1007/s40258-020-00596-3. View